Prognostic Factors in Head and Neck Non-Hodgkin's Lymphoma with Special Reference to Serum Lactic Dehydrogenase and Serum Copper

References

• Lenner P, Roos G, Johansson H, Lindh J, Dige U. Non-Hodgkin Lymphoma: Multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol 1987; 26: 179–83
   PubMed Web of Science ®Google Scholar
• Shigematsu N, Kondo M, Mikata A. Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: The value of the working formulation and need for chemotherapy. Int J Radiat Oncol Biol Phys 1988; 15: 1111–8
   PubMed Web of Science ®Google Scholar
• Barton J H, Osborne B M, Butler J J, et al. Non-Hodgkin's lymphoma of the tonsil: A clinicopathological study of 65 cases. Cancer 1984; 53: 86–95
   PubMed Web of Science ®Google Scholar
• Fujitani T, Takahara T, Hattori H, Imajo Y, Ogasawara H. Radiotherapy for non-Hodgkin's lymphoma in palatine tonsil. Cancer 1984; 54: 1288–92
   PubMed Web of Science ®Google Scholar
• Jacob C, Hoppe R T. Non-Hodgkin's lymphoma of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985; 2: 357–64
   Google Scholar
• Mill W B, Lee F A, Franssila K O. Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 1980; 45: 653–61
   PubMed Web of Science ®Google Scholar
• Shibuya H, Kamiyama R, Watanabe I, Horiuchi J, Suzuki S. Stage I and II Waldeyer's ring and oral-sinonasal non-Hodgkin's lymphoma. Cancer 1987; 59: 940–4
   PubMed Web of Science ®Google Scholar
• Saul S H, Kapadia S B. Primary lymphoma of Waldeyer's ring: clinicopathological study of 68 cases. Cancer 1985; 56: 157–66
   PubMed Web of Science ®Google Scholar
• Shimm D S, Dosoretz D E, Harris N L, Pilch B Z, Linggood M D, Wang C C. Radiation therapy of Waldeyer's ring lymphoma. Cancer 1984; 54: 426–31
   PubMed Web of Science ®Google Scholar
• Shirato H, Tsujii H, Arimoto T, et al. Early stage head and neck non-Hodgkin's lymphoma: The effect of tumor burden on prognosis. Cancer 1986; 58: 2312–19
   PubMed Web of Science ®Google Scholar
• Hcerni B, Sotto J J, Eghbali H, Sotto M F, Hcerni-Simon G, Pegourié B. Non-Hodgkin's malignant lymphoma in patients older than 80; 70 cases. Cancer 1988; 61: 2057–9
   PubMedGoogle Scholar
• Bajetta E, Valagussa P, Bonadonna G, et al. Combined modality treatment for stage I–II non-Hodgkin's lymphoma: CVP versus BACOP chemotherapy. Int J Radiat Oncol Biol Phys 1988; 15: 3–12
   PubMed Web of Science ®Google Scholar
• Nabholtz J-M, Friedman S, Bastien H, Cuisenier J, Horiot J-C, Guerrin J. A clinico-pathological and prognostic analysis of non-Hodgkin lymphoma. A study of 203 patients. Acta Oncol 1988; 27: 489–95
   PubMed Web of Science ®Google Scholar
• Cohen Y, Epelbaum R, Ben-Shahar M, Ron Y, Haim N. Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). Acta Oncol 1988; 27: 531–5
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shibuya H, Yoshimatsu S, Suzuki S. Ultrasonically guided staging splenic tissue core biopsy in patients with non-Hodgkin's lymphoma. Cancer 1987; 60: 879–82
   PubMed Web of Science ®Google Scholar
• Cox D R. Proportional hazards model. Analysis of survival data, D R Cox, D Oakes. Chapman & Hall, Cambridge 1985; 91–111
   Google Scholar
• Connors J M, Klimo P, Fairey R N, Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically agressive lymphoma. Ann Intern Med 1987; 107: 25–30
   PubMed Web of Science ®Google Scholar
• Mauch P, Leonard R, Skarin A, et al. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I–II non-Hodgkin's Lymphoma. J Clin Oncol 1985; 3: 1301–8
   PubMed Web of Science ®Google Scholar
• McLaughlin P, Fuller L M, Velasques W S, Sullivan-Halley J A, Butler J J, Cabanillas F. Stage I–II follicular lymphoma: Treatment result for 76 patients. Cancer 1986; 58: 1596–602
   PubMed Web of Science ®Google Scholar
• Nissen N I, Ersboll J, Hansen H S, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage-I–II non-Hodgkin's lymphoma. Cancer 1983; 52: 1–7
   PubMed Web of Science ®Google Scholar
• Parlier Y, Gorin N C, Najman A, Stachowiak J, Duhamel G. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of Adriamycin in the treatment of adult non-Hodgkin's lymphoma: A report of 131 cases. Cancer 1982; 50: 401–9
   PubMed Web of Science ®Google Scholar
• Tubiana M, Carde P, Burgers J MV, Cosset J M, van Glabbeke M, Somers R. Prognostic factors in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1986; 12: 503–14
   PubMed Web of Science ®Google Scholar
• Lukes R J, Parker J W, Tylor C R, Tindle B H, Cramer A D, Lincoln T L. Immunologic approach to non-Hodgkin's lymphoma and related leukemias. Analysis of the results of multiparameters studies of 425 cases. Semin Hematol 1978; 15: 322–51
   PubMed Web of Science ®Google Scholar
• Margerison A CF, Mann J R. Serum copper, serum ceruloplasmin and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma and non-malignant lymphadenopathy. Cancer 1985; 55: 1501–6
   PubMed Web of Science ®Google Scholar
• Shah-Reddy I, Khilanali P, Bishop C R. Serum copper levels in non-Hodgkin's lymphoma. Cancer 1980; 45: 2156–9
   PubMed Web of Science ®Google Scholar